Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease.

Ji Min Lee Shu Chen Wei Kang Moon Lee Byong Duk Ye Ren Mao Hyun Soo Kim Soo Jung Park Sang Hyoung Park Eun Hye Oh Jong-Pil Im Byeong Ik Jang Dae Bum Kim Ken Takeuchi

Published in: Gut and liver (2021)

Liver dysfunction due to HBV reactivation can occur in HBV-infected IBD patients treated with anti-TNF-α agents. Careful monitoring is needed in these patients, and antivirals should be administered, especially to those with chronic HBV infection.

Keyphrases

hepatitis b virus
patients undergoing
liver failure
end stage renal disease
rheumatoid arthritis
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
oxidative stress
patient reported outcomes
ulcerative colitis
drug induced